Profile | GDS5420 / 228435_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 696.7 | 73 |
GSM1296119 | B_lesional_pre-dose | 3040.89 | 94 |
GSM1296076 | C_lesional_pre-dose | 3576.03 | 94 |
GSM1296092 | D_lesional_pre-dose | 3045.06 | 93 |
GSM1296103 | E_lesional_pre-dose | 1545.42 | 86 |
GSM1296078 | F_lesional_pre-dose | 3557.57 | 94 |
GSM1296107 | G_lesional_pre-dose | 2456.69 | 91 |
GSM1296109 | H_lesional_pre-dose | 1344.93 | 84 |
GSM1296080 | I_lesional_pre-dose | 472.59 | 67 |
GSM1296090 | J_lesional_pre-dose | 3053.37 | 93 |
GSM1296074 | K_lesional_pre-dose | 2477.73 | 90 |
GSM1296111 | L_lesional_pre-dose | 2942.8 | 94 |
GSM1296099 | M_lesional_pre-dose | 1935.47 | 89 |
GSM1296086 | O_lesional_pre-dose | 2077.58 | 89 |
GSM1296117 | P_lesional_pre-dose | 2567.76 | 92 |
GSM1296113 | Q_lesional_pre-dose | 2768.46 | 94 |
GSM1296096 | R_lesional_pre-dose | 2099.05 | 90 |
GSM1296105 | S_lesional_pre-dose | 1118.46 | 81 |
GSM1296098 | T_lesional_pre-dose | 509.1 | 68 |
GSM1296101 | U_lesional_pre-dose | 1187.86 | 82 |
GSM1296121 | V_lesional_pre-dose | 2753.56 | 93 |
GSM1296088 | W_lesional_pre-dose | 1205.49 | 82 |
GSM1296082 | X_lesional_pre-dose | 3709.17 | 94 |
GSM1296115 | Y_lesional_pre-dose | 3367.79 | 95 |
GSM1296084 | Z_lesional_pre-dose | 1512.44 | 85 |
GSM1296072 | B_lesional_day8 | 2875.81 | 94 |
GSM1296069 | L_lesional_day8 | 2059.32 | 90 |
GSM1296071 | P_lesional_day8 | 1905.38 | 90 |
GSM1296070 | Y_lesional_day8 | 2852.27 | 94 |
GSM1296073 | V_lesional_day8 | 2646.23 | 92 |
GSM1296034 | A_lesional_day15 | 380.08 | 62 |
GSM1296041 | G_lesional_day15 | 3312.82 | 94 |
GSM1296035 | R_lesional_day15 | 1871.12 | 88 |
GSM1296038 | U_lesional_day15 | 2087.6 | 89 |
GSM1296047 | B_lesional_day15 | 2438.14 | 92 |
GSM1296039 | E_lesional_day15 | 3712.86 | 94 |
GSM1296042 | H_lesional_day15 | 2429.46 | 92 |
GSM1296043 | L_lesional_day15 | 2221.78 | 91 |
GSM1296037 | M_lesional_day15 | 1462.99 | 85 |
GSM1296046 | P_lesional_day15 | 2726.86 | 94 |
GSM1296044 | Q_lesional_day15 | 2714.59 | 94 |
GSM1296045 | Y_lesional_day15 | 2846.6 | 94 |
GSM1296025 | C_lesional_day15 | 434.3 | 65 |
GSM1296033 | D_lesional_day15 | 1922.27 | 89 |
GSM1296027 | I_lesional_day15 | 1200.1 | 81 |
GSM1296032 | J_lesional_day15 | 1298.21 | 83 |
GSM1296024 | K_lesional_day15 | 320.19 | 60 |
GSM1296031 | W_lesional_day15 | 1458.11 | 85 |
GSM1296028 | X_lesional_day15 | 1616.19 | 86 |
GSM1296029 | Z_lesional_day15 | 920.6 | 77 |
GSM1296026 | F_lesional_day15 | 786.42 | 75 |
GSM1296030 | O_lesional_day15 | 1109.42 | 80 |
GSM1296040 | S_lesional_day15 | 1352.18 | 84 |
GSM1296036 | T_lesional_day15 | 572.84 | 69 |
GSM1296048 | V_lesional_day15 | 2760.75 | 93 |
GSM1296059 | A_lesional_day43 | 1413.12 | 84 |
GSM1296066 | G_lesional_day43 | 2710.75 | 93 |
GSM1296060 | R_lesional_day43 | 2090.25 | 90 |
GSM1296063 | U_lesional_day43 | 2900.68 | 93 |
GSM1296064 | E_lesional_day43 | 3725.76 | 94 |
GSM1296067 | H_lesional_day43 | 1420.7 | 85 |
GSM1296062 | M_lesional_day43 | 906.37 | 77 |
GSM1296068 | Q_lesional_day43 | 2301.18 | 92 |
GSM1296050 | C_lesional_day43 | 1611.83 | 86 |
GSM1296057 | D_lesional_day43 | 2529.97 | 92 |
GSM1296052 | I_lesional_day43 | 1170.56 | 81 |
GSM1296054 | J_lesional_day43 | 966.29 | 78 |
GSM1296049 | K_lesional_day43 | 617.7 | 71 |
GSM1296055 | W_lesional_day43 | 1938.7 | 89 |
GSM1296053 | X_lesional_day43 | 577 | 70 |
GSM1296058 | Z_lesional_day43 | 1877.94 | 88 |
GSM1296051 | F_lesional_day43 | 2242.81 | 90 |
GSM1296056 | O_lesional_day43 | 2436.78 | 91 |
GSM1296065 | S_lesional_day43 | 2812.84 | 94 |
GSM1296061 | T_lesional_day43 | 396.24 | 63 |
GSM1296095 | A_non-lesional_pre-dose | 2626.49 | 92 |
GSM1296120 | B_non-lesional_pre-dose | 2808.36 | 93 |
GSM1296077 | C_non-lesional_pre-dose | 714.16 | 74 |
GSM1296093 | D_non-lesional_pre-dose | 778.35 | 75 |
GSM1296104 | E_non-lesional_pre-dose | 3553.28 | 94 |
GSM1296079 | F_non-lesional_pre-dose | 956.78 | 78 |
GSM1296108 | G_non-lesional_pre-dose | 2671.53 | 93 |
GSM1296110 | H_non-lesional_pre-dose | 1556.17 | 87 |
GSM1296081 | I_non-lesional_pre-dose | 633.85 | 72 |
GSM1296091 | J_non-lesional_pre-dose | 3416.04 | 95 |
GSM1296075 | K_non-lesional_pre-dose | 2023.76 | 89 |
GSM1296112 | L_non-lesional_pre-dose | 1889.67 | 90 |
GSM1296100 | M_non-lesional_pre-dose | 1927.38 | 89 |
GSM1296087 | O_non-lesional_pre-dose | 1843.9 | 87 |
GSM1296118 | P_non-lesional_pre-dose | 2157.5 | 91 |
GSM1296114 | Q_non-lesional_pre-dose | 2915.46 | 94 |
GSM1296097 | R_non-lesional_pre-dose | 2230.01 | 90 |
GSM1296106 | S_non-lesional_pre-dose | 1958.46 | 89 |
GSM1296102 | U_non-lesional_pre-dose | 933.74 | 78 |
GSM1296122 | V_non-lesional_pre-dose | 1648.21 | 87 |
GSM1296089 | W_non-lesional_pre-dose | 1727.62 | 88 |
GSM1296083 | X_non-lesional_pre-dose | 630.88 | 71 |
GSM1296116 | Y_non-lesional_pre-dose | 2632.31 | 93 |
GSM1296085 | Z_non-lesional_pre-dose | 1675.49 | 87 |